20466 ⎘
Medicinal preparations containing organic active ingredients; Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
INTRAOCULAR IMPLANT WITH HIGH LOADING OF A PROSTAMIDE
#2PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT
#3PHARMACEUTICAL COMPOSITION FOR IMPROVING CARDIAC FUNCTION
#4PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT
#5PHARMACEUTICAL COMPOSITION FOR COMBINATION THERAPY COMPRISING MELATONIN AND PROSTAGLANDIN E2 FOR TREATING INTESTINAL EPITHELIAL INJURY AS AN ACTIVE INGREDIENT
#6BIODEGRADABLE DRUG-POLYMER CONJUGATE
#7PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT
#8COMBINATION THERAPY
#9Intraocular implant with high loading of a prostamide
#10Compositions for treating glaucoma or reducing intraocular pressure
#11Combination therapy
#12METHODS FOR TREATING DISEASES ASSOCIATED WITH CILIOPATHIES
#13Composition and method of using eicosanoyl-5-hydroxytryptamide for treating neurodegenerative disorders
#14PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT
#15Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor Antagonists
#16Combination Therapy
#17Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor Antagonists
#18Combination therapy
#19Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor Antagonists
#20TWO PART FORMULATION SYSTEM FOR OPHTHALMIC DELIVERY
#21Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor Antagonists
#22COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS USING NON-NATURALLY OCCURRING PROSTAGLANDINS
#23Combination therapy
#24Combination therapy
#25Prostamide-containing intraocular implant
#26Methods for fat reduction
#27COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS USING NON-NATURALLY OCCURRING PROSTAGLANDINS
#28Methods of Treating Hepatorenal Syndrome and Hepatic Encephalopathy with Thromboxane-A2 Receptor Antagonists
#29Combination therapy
#30Two part formulation system for ophthalmic delivery
#31SKIN WOUND HEALING AND SCAR REDUCTION WITH PROSTAGLANDIN EP4 AGONIST COMBINATIONS
#32SOLID FORMS OF AN ALPHA, OMEGA DI-SUBSTITUTED DIHYDROXY CYCLOPENTYL COMPOUND AND METHODS FOR THE PREPARATION AND USE THEREOF
#33Microsphere Drug Delivery System for Sustained Intraocular Release
#34Combination therapy
#35Sustained release bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction
#36Methods for fat reduction
#37Combination therapy
#38Two part formulation system for ophthalmic delivery
#39STABLE AQUEOUS COMPOSITIONS OF PROSTGLANDIN AGONIST PRODRUGS AND METHODS FOR USE THEREOF
#40Prostamide-containing intraocular implant
#41Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension
#42Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
#43Treatment of inflammatory bowel disease
#44Compounds to fibroblast growth factor receptor-3 (FGFR3) and methods of treatment
#45Treatment of inflammatory bowel disease
#46SUSTAINED RELEASE BIMATOPROST, BIMATOPROST ANALOGS, PROSTAMIDES AND PROSTAGLANDINS FOR FAT REDUCTION
#47Combination therapy
#48Combination therapy for glaucoma
#49ANTI-CONSTIPATION COMPOSITION
#50Prostamides for the treatment of glaucoma and related diseases
#51Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
#52TWO PART FORMULATION SYSTEM FOR OPTHALMIC DELIVERY
#53Anti-constipation composition
#54PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DISEASES ASSOCIATED WITH DECREASE IN BONE MASS COMPRISING EP4 AGONIST AS ACTIVE INGREDIENT
#55COMPOUNDS AND METHODS FOR SKIN REPAIR
#56COMPOSITIONS AND METHODS FOR TREATING CORNEAL HAZE
#57Anti-constipation composition
#58NON-ACIDIC CYCLOPENTANE HEPTANOIC ACID, 2-CYCLOALKYL OR ARYLALKYL DERIVATIVES AS THERAPEUTIC AGENTS
#59Geminal dialkyl prostanoids
#60Prostaglandins and analogues as agents for lowering intraocular pressure
#61Combination Therapy For Glaucoma
#62STABLE AQUEOUS COMPOSITIONS OF PROSTGLANDIN AGONIST PRODRUGS AND METHODS FOR USE THEREOF
#63Therapeutic substituted cyclopentanes
#64Blood flow promoters for cauda equina tissues
#65METHODS AND COMPOSITIONS FOR TREATING GASTROINTENSTIAL DISORDERS
#66METHODS OF TREATMENT OF UTERINE PATHOLOGICAL CONDITIONS
#67Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient
#68Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
#69Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
#70Compositions and Methods for the Enhancement of Chemotherapy with Microbial Cytotoxins
#71COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS USING NON-NATURALLY OCCURRING PROSTAGLANDINS
#72Prostamides for the treatment of glaucoma and related diseases
#73Preventive and/or remedy for lower urinary tract diseases containing EPagonist
#74Blood flow promoters for cauda equina tissues
#75Prostaglandins and analogues as agents for lowering intraocular pressure
#76Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
#77Anti-constipation composition
#78Treatment of inflammatory bowel disease
#79Combination therapy for glaucoma treatment
#80Treatment of inflammatory bowel disease
#81Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as the active ingredient